Timothy Carll to Humans
This is a "connection" page, showing publications Timothy Carll has written about Humans.
Connection Strength
0.320
-
Viscoelastic Testing Methods. Adv Clin Chem. 2023; 117:1-52.
Score: 0.030
-
Viscoelastic testing: Critical appraisal of new methodologies and current literature. Int J Lab Hematol. 2023 Oct; 45(5):643-658.
Score: 0.030
-
Tissue Contamination During Transportation of Formalin-Fixed, Paraffin-Embedded Blocks. Am J Clin Pathol. 2022 07 01; 158(1):96-104.
Score: 0.028
-
Peripheral Blood Smear Detection of Asymptomatic Central Line Infection in a Patient With Sickle Cell Disease. J Pediatr Hematol Oncol. 2022 Apr 01; 44(3):98-99.
Score: 0.027
-
Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy. Transfusion. 2022 04; 62(4):916-918.
Score: 0.027
-
The Effect of RBC Transfusion on Oxygenation Status. Am J Clin Pathol. 2022 03 03; 157(3):477.
Score: 0.027
-
Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement. Blood Adv. 2020 10 13; 4(19):4924-4928.
Score: 0.025
-
Basic principles of viscoelastic testing. Transfusion. 2020 10; 60 Suppl 6:S1-S9.
Score: 0.024
-
An abdominal wall mass of exogenous insulin amyloidosis in setting of metastatic sarcoma. J Cutan Pathol. 2020 Apr; 47(4):406-408.
Score: 0.023
-
A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant. Pediatr Blood Cancer. 2024 Aug; 71(8):e31086.
Score: 0.008
-
Transfusion management and hemoglobin-based oxygen carrier treatment in a patient with anti-Rh17 antibody. Transfusion. 2024 Jun; 64(6):1161-1166.
Score: 0.008
-
Sensitivity and specificity of thromboelastography for hyperfibrinolysis: Comparison of TEG 5000 and TEG 6S CK LY30 systems. Am J Clin Pathol. 2023 11 02; 160(5):455-465.
Score: 0.008
-
Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab. Transfusion. 2022 07; 62(7):1446-1451.
Score: 0.007
-
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators. Haematologica. 2022 04 01; 107(4):966-969.
Score: 0.007
-
Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). J Clin Apher. 2022 Feb; 37(1):117-121.
Score: 0.007
-
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. J Clin Oncol. 2021 08 20; 39(24):2647-2655.
Score: 0.006
-
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target. Melanoma Res. 2021 02 01; 31(1):27-37.
Score: 0.006
-
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. Clin Cancer Res. 2020 12 15; 26(24):6437-6444.
Score: 0.006
-
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201). Clin Cancer Res. 2020 02 15; 26(4):804-811.
Score: 0.006
-
Assessment of Consistency Between Peer-Reviewed Publications and Clinical Trial Registries. JAMA Ophthalmol. 2019 05 01; 137(5):552-556.
Score: 0.006
-
Heterotopic Gastrointestinal Cyst of the Oral Cavity Radiology-Pathology Correlation. Head Neck Pathol. 2019 Dec; 13(4):668-670.
Score: 0.005